IPO

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

Vantage Corp finalizes its PJ Marine Singapore acquisition, a strategic move into China's lucrative market despite recent financial headwinds.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

Scorpio Tankers locks in a five-year, $105M charter deal for two tankers, a strategic move to ensure revenue stability amid a volatile shipping market.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Fresh off a massive 240% revenue surge, Nutex Health prepares to showcase its micro-hospital model and physician-led strategy to top global investors.

Smart scooter giant Niu Technologies posted record annual sales driven by China, but a sharp Q4 drop, especially abroad, clouds its global outlook.

Fintech leader Inbank secures new capital to expand its car-as-a-service arm, Mobire, signaling strong investor belief in its embedded finance strategy.

For just $80,000, Pulsar Helium has acquired key land rights, positioning Michigan's Upper Peninsula as a potential new source for the critical gas.

E-commerce logistics firm Globavend Holdings raised $1.4M in a direct offering, but its stock tumbled. A look at the deal, the market, and what's next.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

A landmark lawsuit claims the city’s failure to regulate vendors has decimated a community market, threatening student scholarships and small businesses.

StickIt Technologies bets on a complex share consolidation and capital raise to survive, but are the terms a red flag for its investors and future?

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

The crypto payment firm rolled out Ethereum and BNB support, a new Bitcoin explorer, and developer tools in a pivotal year. Is it enough to challenge the giants?

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.